Cargando…
Emerging evidence of the molecular landscape specific for hematogenous metastasis from gastric cancer
Gastric cancer (GC) is one of the most frequently diagnosed cancers in the world. Most GC patients are diagnosed when the cancer is in an advanced stage, and consequently, some develop metastatic lesions that generally cause cancer-related death. Metastasis establishment is affected by various condi...
Autores principales: | Shimizu, Dai, Kanda, Mitsuro, Kodera, Yasuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033711/ https://www.ncbi.nlm.nih.gov/pubmed/29988904 http://dx.doi.org/10.4251/wjgo.v10.i6.124 |
Ejemplares similares
-
GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer
por: Shimizu, Dai, et al.
Publicado: (2017) -
Survival times are similar among patients with peritoneal, hematogenous, and nodal recurrences after curative resections for gastric cancer
por: Sawaki, Koichi, et al.
Publicado: (2020) -
Hematogenous Gastric Metastasis of Pancreatic Cancer
por: Sasajima, Junpei, et al.
Publicado: (2016) -
Amido-Bridged Nucleic Acid-Modified Antisense Oligonucleotides Targeting SYT13 to Treat Peritoneal Metastasis of Gastric Cancer
por: Kanda, Mitsuro, et al.
Publicado: (2020) -
Long-lasting discussion: Adverse effects of intraoperative blood loss and allogeneic transfusion on prognosis of patients with gastric cancer
por: Nakanishi, Koki, et al.
Publicado: (2019)